Loading news...
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 4, 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that the Company has filed its Annual Report on Form 20-F for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the "SEC").
Cellebrite DI Ltd. (CLBT) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Addition of Unmanned Aerial Vehicle (UAV) forensic capabilities extends Cellebrite's AI-powered platform to one of the fastest-growing data sources in defense and public safety TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 2, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, closed its acquisition of SCG Canada, Inc., a leading provider of hand-held digital forensics solutions that enable access to more than 80 of the most common UAVs.
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 24, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced the Company will participate in the upcoming Morgan Stanley Technology, Media & Telecom Conference.
Granite Investment Partners LLC purchased a new position in shares of Cellebrite DI Ltd. (NASDAQ: CLBT) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 615,527 shares of the company's stock, valued at approximately $11,406,000. Granite Investment Partners LLC owned 0.26% of
Cellebrite DI (NASDAQ: CLBT) executives said the company finished fiscal 2025 with a "solid" fourth quarter and highlighted expanding adoption of its cloud and software offerings, rising profitability, and a slate of product and go-to-market initiatives aimed at reaccelerating growth in 2026. Management also discussed progress integrating the recently acquired Corellium business and announced an agreement
Cellebrite DI Ltd. (CLBT) Q4 2025 Earnings Call Transcript
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.14 per share, in line with the Zacks Consensus Estimate.
Total ARR grew 21% to $480.8 million; Revenue grew 18% to $128.8 million Net income of $21.3 million supports non-GAAP net income of $36.7 million and adjusted EBITDA of $38.3 million, 29.8% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 11, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2025.
An explanation of why software stocks - especially SaaS - are being structurally disrupted by AI, and how investors can identify survivors.
New York State Common Retirement Fund raised its holdings in Cellebrite DI Ltd. (NASDAQ: CLBT) by 62.4% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 145,433 shares of the company's stock after acquiring an additional 55,863 shares during
97% cite smartphones as top evidence source, up 24 points from 2024 95% agree digital evidence increases solvability, yet 94% say complexity strains caseloads 65% believe AI can accelerate investigations, but one-third say policies prevent its use Cloud receptiveness hit 42%, yet two-thirds still rely on physical media TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 5, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today unveiled its 2026 Industry Trends Report, which surveyed 1,200 practitioners across 63 countries, marking the company's seventh annual report on how organizations collect, manage and analyze digital evidence.
Wealth Enhancement Advisory Services LLC boosted its stake in Cellebrite DI Ltd. (NASDAQ: CLBT) by 40.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 359,764 shares of the company's stock after acquiring an additional 103,568 shares during the
During the quarter, we initiated new positions in nLIGHT, Guardant Health and Cellebrite. We also added to Bruker, Hexcel and Penumbra during the quarter. Along with Insmed, we also ended our investment campaigns in Integer Holdings and SharkNinja during the quarter.
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 21, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2025 financial results before the U.S. markets open on Wednesday, February 11, 2026.
Cellebrite DI (NASDAQ: CLBT - Get Free Report) and Penguin Solutions (NASDAQ: PENG - Get Free Report) are both computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Volatility and Risk Cellebrite DI has
Squarepoint Ops LLC acquired a new position in Cellebrite DI Ltd. (NASDAQ: CLBT) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 42,199 shares of the company's stock, valued at approximately $675,000. A number of other hedge funds have
Shares of Cellebrite DI Ltd. (NASDAQ: CLBT - Get Free Report) have earned an average rating of "Moderate Buy" from the five brokerages that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating and four have issued a buy rating on the company. The average 12-month price
Needham analysts met with 12 companies before quiet period. Ratings and price targets by analyst Mike Cikos.
Norwood initiated Cellebrite position and now holds 230,671 shares, worth an estimated $4.27 million. The stake represents 3.68% of 13F reportable assets under management.